Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001933414-25-000046
Filing Date
2025-04-15
Accepted
2025-04-15 20:36:00
Documents
1
Period of Report
2025-04-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1744763754.html 4  
1 FORM 4 wk-form4_1744763754.xml 4 3807
  Complete submission text file 0001933414-25-000046.txt   5298
Mailing Address C/O MIRAGEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD, #100 BOULDER CO 80301
Business Address
Levy Adam Scott (Reporting) CIK: 0001693134 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41614 | Film No.: 25841011

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Issuer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)